Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Bu L, Li R, Liu H, Feng W, Xiong X, Zhao H, Vollrath D, Shen B, Cheng Z.

Radiology. 2014 Jul;272(1):174-83. doi: 10.1148/radiol.14132042. Epub 2014 Apr 20.

2.
3.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
4.

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Flores LG 2nd, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG.

Mol Imaging Biol. 2013 Apr;15(2):175-85. doi: 10.1007/s11307-012-0588-5.

5.

In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET.

Fuchs K, Kohlhofer U, Quintanilla-Martinez L, Lamparter D, Kötter I, Reischl G, Röcken M, Pichler BJ, Kneilling M.

J Nucl Med. 2013 Jan;54(1):151-8. doi: 10.2967/jnumed.112.106740. Epub 2012 Dec 4.

6.

18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.

Yui J, Maeda J, Kumata K, Kawamura K, Yanamoto K, Hatori A, Yamasaki T, Nengaki N, Higuchi M, Zhang MR.

J Nucl Med. 2010 Aug;51(8):1301-9. doi: 10.2967/jnumed.109.072223. Epub 2010 Jul 21.

7.

Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.

Mou T, Zhao Z, Fang W, Peng C, Guo F, Liu B, Ma Y, Zhang X.

J Nucl Med. 2012 Mar;53(3):472-9. doi: 10.2967/jnumed.111.088096. Epub 2012 Feb 2.

8.

A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.

Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M.

J Radiat Res. 2013 Nov 1;54(6):1078-84. doi: 10.1093/jrr/rrt033. Epub 2013 Apr 14.

9.

(18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.

Iagaru A, Mosci C, Shen B, Chin FT, Mittra E, Telli ML, Gambhir SS.

Radiology. 2014 Nov;273(2):549-59. doi: 10.1148/radiol.14140028. Epub 2014 Jul 16.

PMID:
25033190
10.

18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.

Hackel BJ, Kimura RH, Miao Z, Liu H, Sathirachinda A, Cheng Z, Chin FT, Gambhir SS.

J Nucl Med. 2013 Jul;54(7):1101-5. doi: 10.2967/jnumed.112.110759. Epub 2013 May 13.

11.

2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

Wang JL, Parhi AK, Oya S, Lieberman B, Kung MP, Kung HF.

Nucl Med Biol. 2008 May;35(4):447-58. doi: 10.1016/j.nucmedbio.2008.02.009.

12.

Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model.

Wang H, Machtaler S, Bettinger T, Lutz AM, Luong R, Bussat P, Gambhir SS, Tranquart F, Tian L, Willmann JK.

Radiology. 2013 Jun;267(3):818-29. doi: 10.1148/radiol.13122509. Epub 2013 Jan 31.

13.

Melanin-targeted preclinical PET imaging of melanoma metastasis.

Ren G, Miao Z, Liu H, Jiang L, Limpa-Amara N, Mahmood A, Gambhir SS, Cheng Z.

J Nucl Med. 2009 Oct;50(10):1692-9. doi: 10.2967/jnumed.109.066175. Epub 2009 Sep 16.

14.

Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.

Wu A, Zheng H, Kraenzle J, Biller A, Vanover CD, Proctor M, Sherwood L, Steffen M, Ng C, Mollura DJ, Jonsson CB.

ILAR J. 2012;53(1):E9-21. doi: 10.1093/ilar.53.1.9.

15.

A novel aliphatic 18F-labeled probe for PET imaging of melanoma.

Liu H, Liu S, Miao Z, Jiang H, Deng Z, Hong X, Cheng Z.

Mol Pharm. 2013 Sep 3;10(9):3384-91. doi: 10.1021/mp400225s. Epub 2013 Aug 22.

16.

Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.

Challapalli A, Sharma R, Hallett WA, Kozlowski K, Carroll L, Brickute D, Twyman F, Al-Nahhas A, Aboagye EO.

J Nucl Med. 2014 Feb;55(2):256-63. doi: 10.2967/jnumed.113.129577.

17.

In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).

Wanger-Baumann CA, Mu L, Honer M, Belli S, Alf MF, Schubiger PA, Krämer SD, Ametamey SM.

Neuroimage. 2011 Jun 1;56(3):984-91. doi: 10.1016/j.neuroimage.2011.03.024. Epub 2011 Mar 21.

PMID:
21406237
18.

In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.

Khayum MA, Doorduin J, Antunes IF, Kwizera C, Zijlma R, den Boer JA, Dierckx RA, de Vries EF.

Nucl Med Biol. 2015 Jun;42(6):561-9. doi: 10.1016/j.nucmedbio.2015.02.003. Epub 2015 Feb 11.

19.

Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Maier FC, Kneilling M, Reischl G, Cay F, Bukala D, Schmid A, Judenhofer MS, Röcken M, Machulla HJ, Pichler BJ.

Radiat Oncol. 2011 Nov 25;6:165. doi: 10.1186/1748-717X-6-165.

20.
Items per page

Supplemental Content

Write to the Help Desk